Acadian Asset Management LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Acadian Asset Management LLC significantly increased its holdings in Intuitive Surgical, Inc. by 120% in Q1, now owning a total of 48,093 shares valued at approximately $23.81 million.
• Several other institutional investors also boosted their positions in Intuitive Surgical during the same quarter, with Chilton Capital Management leading at a 614.3% increase.
• Intuitive Surgical's stock recently posted a 3.8% decline and was trading at around $449.98, despite strong earnings results showing a beat on EPS estimates and a revenue increase of 21.4% year over year.

Acadian Asset Management LLC grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 120.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 48,093 shares of the medical equipment provider's stock after purchasing an additional 26,237 shares during the period. Acadian Asset Management LLC's holdings in Intuitive Surgical were worth $23,808,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of ISRG. Brighton Jones LLC raised its holdings in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares during the period. Bank Pictet & Cie Europe AG raised its holdings in shares of Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the period. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $488,000. Occudo Quantitative Strategies LP purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth approximately $1,064,000. Finally, NorthRock Partners LLC raised its holdings in shares of Intuitive Surgical by 209.6% in the fourth quarter. NorthRock Partners LLC now owns 4,535 shares of the medical equipment provider's stock worth $2,367,000 after buying an additional 3,070 shares during the period. 83.64% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on ISRG shares. Wells Fargo & Company raised their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Evercore ISI raised their price objective on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Finally, Wall Street Zen raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the transaction, the director owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Stock Down 1.4%

Shares of Intuitive Surgical stock traded down $6.17 during trading on Friday, reaching $449.68. The company's stock had a trading volume of 2,218,377 shares, compared to its average volume of 2,114,573. The company has a market cap of $161.20 billion, a price-to-earnings ratio of 62.72, a P/E/G ratio of 4.78 and a beta of 1.61. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a 50-day simple moving average of $485.67 and a two-hundred day simple moving average of $508.21.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter in the previous year, the firm posted $1.78 EPS. The firm's revenue was up 21.4% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.